These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 10563496)
1. Absence of Fas (CD95) and FasL (CD95L) immunohistochemical expression suggests Fas/FasL-mediated apoptotic signal is not relevant in cutaneous Kaposi's sarcoma lesions. Fernández-Figueras MT; Armengol P; Puig L; Molinero JL; Esquius M; Sirera G; Ariza A J Cutan Pathol; 1999 Oct; 26(9):417-23. PubMed ID: 10563496 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-4 receptor expression in vivo on human AIDS-related Kaposi's sarcoma. Varricchio F; Husain SR; Leland P; Gill P; Puri RK Oncol Res; 1997; 9(9):495-503. PubMed ID: 9495455 [TBL] [Abstract][Full Text] [Related]
3. Resistance of AIDS-associated Kaposi's sarcoma cells to Fas-mediated apoptosis. Mori S; Murakami-Mori K; Jewett A; Nakamura S; Bonavida B Cancer Res; 1996 Apr; 56(8):1874-9. PubMed ID: 8620507 [TBL] [Abstract][Full Text] [Related]
4. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape? Ni X; Hazarika P; Zhang C; Talpur R; Duvic M Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of c-Met in Kaposi's sarcoma according to progression stage and HIV infection status. Puig L; Fernández-Figueras MT; Penín RM; Esquius M; Alomar A; Ariza A J Cutan Pathol; 1999 May; 26(5):227-31. PubMed ID: 10408347 [TBL] [Abstract][Full Text] [Related]
6. Fas (APO-1/CD95) ligand and Fas expression in renal cell carcinomas: correlation with the prognostic factors. Kim YS; Kim KH; Choi JA; Lee JH; Kim HK; Won NH; Kim I Arch Pathol Lab Med; 2000 May; 124(5):687-93. PubMed ID: 10782148 [TBL] [Abstract][Full Text] [Related]
7. Frequent downregulation of Fas (CD95) expression and function in melanoma. Bullani RR; Wehrli P; Viard-Leveugle I; Rimoldi D; Cerottini JC; Saurat JH; Tschopp J; French LE Melanoma Res; 2002 Jun; 12(3):263-70. PubMed ID: 12140383 [TBL] [Abstract][Full Text] [Related]
8. Fas and Fas ligand expression in tumor cells and in vascular smooth-muscle cells of colonic and renal carcinomas. Peduto Eberl L; Guillou L; Saraga E; Schröter M; French LE; Tschopp J; Juillerat-Jeanneret L Int J Cancer; 1999 May; 81(5):772-8. PubMed ID: 10328232 [TBL] [Abstract][Full Text] [Related]
9. Actinomycin D-mediated sensitization of AIDS-Kaposi's sarcoma cells to Fas-mediated apoptosis: involvement of the mitochondrion-dependent pathway. Mori S; Murakami-Mori K; Nakamura S; Bonavida B Int J Oncol; 2002 Apr; 20(4):819-26. PubMed ID: 11894131 [TBL] [Abstract][Full Text] [Related]
10. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC. Hoves S; Krause SW; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M J Immunol; 2003 Jun; 170(11):5406-13. PubMed ID: 12759415 [TBL] [Abstract][Full Text] [Related]
11. Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma. Cai J; Gill PS; Masood R; Chandrasoma P; Jung B; Law RE; Radka SF Am J Pathol; 1994 Jul; 145(1):74-9. PubMed ID: 8030759 [TBL] [Abstract][Full Text] [Related]
12. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients. Dictor M; Rambech E; Way D; Witte M; Bendsöe N Am J Pathol; 1996 Jun; 148(6):2009-16. PubMed ID: 8669485 [TBL] [Abstract][Full Text] [Related]
13. Sensitization of AIDS-Kaposi's sarcoma cells to Apo-2 ligand-induced apoptosis by actinomycin D. Mori S; Murakami-Mori K; Nakamura S; Ashkenazi A; Bonavida B J Immunol; 1999 May; 162(9):5616-23. PubMed ID: 10228045 [TBL] [Abstract][Full Text] [Related]
14. Expression of transforming growth factor beta and transforming growth factor beta receptors on AIDS-associated Kaposi's sarcoma. Ciernik IF; Krayenbühl Ciernik BH; Cockerell CJ; Minna JD; Gazdar AF; Carbone DP Clin Cancer Res; 1995 Oct; 1(10):1119-24. PubMed ID: 9815902 [TBL] [Abstract][Full Text] [Related]
15. Differential expression of p53 and Ki-67 proteins in classic and iatrogenic Kaposi's sarcoma. Hodak E; Hammel I; Feinmesser M; Zelinger A; Maron L; Sulkes J; David M Am J Dermatopathol; 1999 Apr; 21(2):138-45. PubMed ID: 10218673 [TBL] [Abstract][Full Text] [Related]
16. Upregulated expression of Fas and Fas ligand in brain through the spectrum of HIV-1 infection. Elovaara I; Sabri F; Gray F; Alafuzoff I; Chiodi F Acta Neuropathol; 1999 Oct; 98(4):355-62. PubMed ID: 10502040 [TBL] [Abstract][Full Text] [Related]
17. A possible role of multidrug resistance-associated protein (MRP) in basic fibroblast growth factor secretion by AIDS-associated Kaposi's sarcoma cells: a survival molecule? Gupta S; Aggarwal S; Nakamura S J Clin Immunol; 1998 Jul; 18(4):256-63. PubMed ID: 9710742 [TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of spindle cells in Kaposi's sarcoma: comparison of cells in lesions and in culture. Kaaya EE; Parravicini C; Ordonez C; Gendelman R; Berti E; Gallo RC; Biberfeld P J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):295-305. PubMed ID: 7552491 [TBL] [Abstract][Full Text] [Related]
19. Phenotypic characteristics of Kaposi's sarcoma tumour cells derived from patch-, plaque- and nodular-stage lesions: analysis of cell cultures isolated from AIDS and non-AIDS patients and review of the literature. Simonart T; Hermans P; Schandene L; Van Vooren JP Br J Dermatol; 2000 Sep; 143(3):557-63. PubMed ID: 10971329 [TBL] [Abstract][Full Text] [Related]
20. Expression of the fibroblast/macrophage marker 1B10 by spindle cells in Kaposi's sarcoma lesions and by Kaposi's sarcoma-derived tumor cells. Simonart T; Degraef C; Heenen M; Hermans P; Van Vooren JP; Noel JC J Cutan Pathol; 2002 Feb; 29(2):72-8. PubMed ID: 12150136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]